Clinical trial
Assessment of the Antiviral Effect of Atorvastatin on Hepatitis C Virus
NCT00403533 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of the Antiviral Effect of Atorvastatin on Hepatitis C Virus
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 2006
- Completion date
- July 31, 2006
- Enrollment
- 10
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.